EUVIMEDOpdag EUVIMED
FallberichtOpen access · CC BY-NC-ND 4.0

When the Podocyte Speaks First

Krishna Mohita Kuruvada iD, Fady Gries, Arjun Wanchoo, Ming Wu, Astrid Weins iD, Kenar D Jhaveri iD

Kidney360 · 2026-07 · 7 (7) · 1651-1654

DOI: 10.34067/kid.0000001225 ↗

At a glance

Fallbericht in Kidney360, published online on 2026-04-20. Written by Krishna Mohita Kuruvada and 5 co-authors. Institution: Division of Kidney Diseases and Hypertension, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New Yo…. Major MEDLINE topics: Hodgkin Disease, Nephrosis, Lipoid, Podocytes, Membrane Proteins. 12 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

We report the case of a 23-year-old woman who developed minimal change disease (MCD) in the postpartum period. Kidney biopsy findings were consistent with MCD, with positive anti-nephrin immunostaining. Her clinical course was complicated by multiple relapses and steroid intolerance, requiring treatment with multiple immunosuppressive therapies. Despite therapy, complete remission was not achieved. A year and a half after the MCD diagnosis, she was diagnosed with Hodgkin lymphoma. After chemotherapy and radiation therapy, the patient finally achieved complete remission of both MCD and Hodgkin lymphoma. This case highlights the complex relationship between MCD and lymphoproliferative disorders. It suggests that anti-nephrin positive MCD, typically considered a primary podocytopathy, may in rare instances represent a paraneoplastic manifestation. In addition, this report highlights the importance of maintaining a high index of suspicion for occult malignancy in young patients with relapsing or refractory MCD, despite biomarkers suggesting primary disease.

Subjects

MeSH terms (MEDLINE)

Hodgkin DiseaseNephrosis, LipoidPodocytesMembrane ProteinsHumansFemaleYoung AdultBiopsyImmunosuppressive AgentsRemission InductionPostpartum Period

Author keywords

chemotherapychronic glomerulonephritisglomerulopathyminimal change diseasenephrotic syndromeonconephrologyproteinuria

Substances

Membrane ProteinsImmunosuppressive Agents

Authors and institutions

  • Division of Kidney Diseases and Hypertension, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York.
  • Manhasset Secondary Schools, Manhasset, New York.
  • Department of Pathology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York.
  • Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

ORCID profiles: Krishna Mohita Kuruvada, Astrid Weins, Kenar D Jhaveri

Cite

APA

Kuruvada, K. M., Gries, F., Wanchoo, A., Wu, M., Weins, A., & Jhaveri, K. D. (2026). When the Podocyte Speaks First. Kidney360, 7(7), 1651-1654. https://doi.org/10.34067/kid.0000001225

Vancouver

Kuruvada KM, Gries F, Wanchoo A, Wu M, Weins A, Jhaveri KD. When the Podocyte Speaks First. Kidney360. 2026;7(7):1651-1654. doi:10.34067/kid.0000001225

BibTeX
@article{Kuruvada2026,
  author = {Kuruvada, Krishna Mohita and Gries, Fady and Wanchoo, Arjun and Wu, Ming and Weins, Astrid and Jhaveri, Kenar D},
  title = {When the Podocyte Speaks First},
  journal = {Kidney360},
  year = {2026},
  volume = {7},
  number = {7},
  pages = {1651--1654},
  doi = {10.34067/kid.0000001225}
}
Start for free →